Annual Cash & Cash Equivalents
$261.90M$1.00M-0.38%
Summary
- Current Value
- As of today, AVTR annual cash & cash equivalents is $261.90M, down -0.38% on
- Historical Performance
- AVTR annual cash & cash equivalents is down -13.19% over the past 3 years, and up +40.28% over the past 5 years
- All-Time High Comparison
- AVTR annual cash & cash equivalents is currently -29.77% below its historical high of $372.90M set on
- 3-Year Low Comparison
- AVTR annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- AVTR annual cash & cash equivalents is higher than 81.95% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $261.90M | -0.4% | -13.2% | +40.3% | – | |
| Quarterly Cash & Cash Equivalents | $251.90M | -11.7% | -5.2% | -32.0% | +35.9% | |
| Price | $12.27 | -44.6% | -40.6% | -57.7% | – | |
| Annual Current Assets | $2.15B | -10.0% | -13.3% | +6.2% | – | |
| Annual Total Liabilities | $6.16B | -20.2% | -36.5% | -15.8% | – | |
| Annual Working Capital | $139.10M | -84.6% | -86.5% | -85.3% | – | |
| Annual Net Income | $711.50M | +121.6% | +24.3% | +1782.3% | +5502.4% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $372.90M | N/A | -29.8% |
| 5Y | $372.90M | -29.8% | |
| All | $372.90M | -29.8% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $261.90M | at low | |
| 5Y | $261.90M | at low | |
| All | $62.90M | +316.4% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $261.90M | -0.4% | |
| $262.90M | -29.5% | |
| $372.90M | +23.6% | |
| $301.70M | +5.3% | |
| $286.60M | +53.5% |
| Year | Value | Change |
|---|---|---|
| $186.70M | +1.1% | |
| $184.70M | -0.4% | |
| $185.40M | +194.8% | |
| $62.90M | - |
FAQ
What is the current annual cash & cash equivalents of AVTR?
As of today, AVTR annual cash & cash equivalents is $261.90M
What is 1-year change in AVTR annual cash & cash equivalents?
AVTR annual cash & cash equivalents is down -0.38% year-over-year
What is 3-year change in AVTR annual cash & cash equivalents?
AVTR annual cash & cash equivalents is down -13.19% over the past 3 years
How far is AVTR annual cash & cash equivalents from its all-time high?
AVTR annual cash & cash equivalents is currently -29.77% below its historical high of $372.90M set on December 31, 2022
How does AVTR annual cash & cash equivalents rank versus sector peers?
AVTR annual cash & cash equivalents is higher than 81.95% of companies in Healthcare sector
When is AVTR next annual earnings release?
The next annual earnings release for AVTR is on
Quarterly Cash & Cash Equivalents
$251.90M$197.50M-43.95%
Summary
- Current Value
- As of today, AVTR quarterly cash & cash equivalents is $251.90M, down -43.95% on
- Historical Performance
- AVTR quarterly cash & cash equivalents is down -11.71% year-over-year, and down -5.16% over the past 3 years
- All-Time High Comparison
- AVTR quarterly cash & cash equivalents is currently -82.34% below its historical high of $1.43B set on
- 3-Year Low Comparison
- AVTR quarterly cash & cash equivalents is +7.24% above its 3-year low of $234.90M reached on
- Sector Comparison
- AVTR quarterly cash & cash equivalents is higher than 73.55% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $251.90M | -44.0% | -11.7% | -5.2% | -32.0% | |
| Annual Cash & Cash Equivalents | $261.90M | – | -0.4% | -13.2% | +40.3% | |
| Price | $12.27 | -9.4% | -44.6% | -40.6% | -57.7% | |
| Quarterly Current Assets | $2.26B | -10.2% | -9.9% | -11.8% | -1.7% | |
| Quarterly Total Liabilities | $6.11B | -5.9% | -16.2% | -28.4% | -17.3% | |
| Quarterly Working Capital | $740.70M | +1312.3% | -15.3% | -26.5% | -36.2% | |
| Quarterly Net Income | -$711.80M | -1200.2% | -1331.5% | -526.2% | -1586.7% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $449.40M | -44.0% | |
| 3Y | $449.40M | -44.0% | |
| 5Y | $1.43B | -82.3% | |
| All | $1.43B | -82.3% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $251.90M | at low | |
| 3Y | $234.90M | +7.2% | |
| 5Y | $172.50M | +46.0% | |
| All | $143.90M | +75.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of AVTR?
As of today, AVTR quarterly cash & cash equivalents is $251.90M
What is AVTR quarterly cash & cash equivalents most recent change?
AVTR quarterly cash & cash equivalents was down -43.95% on September 30, 2025
What is 1-year change in AVTR quarterly cash & cash equivalents?
AVTR quarterly cash & cash equivalents is down -11.71% year-over-year
How far is AVTR quarterly cash & cash equivalents from its all-time high?
AVTR quarterly cash & cash equivalents is currently -82.34% below its historical high of $1.43B set on September 30, 2021
How does AVTR quarterly cash & cash equivalents rank versus sector peers?
AVTR quarterly cash & cash equivalents is higher than 73.55% of companies in Healthcare sector
When is AVTR next earnings release?
The next earnings release for AVTR is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- AVTR Official Website www.avantorsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1722482/000162828025046936/0001628280-25-046936-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1722482/000172248225000015/0001722482-25-000015-index.htm
- AVTR Profile on Yahoo Finance finance.yahoo.com/quote/AVTR
- AVTR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avtr